Advanced search
Publication Cover
Future Cardiology Volume 9, 2013 - Issue 3
Submit an article Journal homepage
118
Views
0
CrossRef citations to date
0
Altmetric
Review

Plasmonic Photothermal Therapy for Atheroregression Below Glagov Threshold

Alexander N KharlamovRotterdam University Medical Center (Erasmus MC) Rotterdam The Netherlands and Department of Science Ural Institute of CardiologyYekaterinburg620144Russia.Tel.: +73 432 575 216 Fax: +73 432 577 079; [email protected]
Pages 405-425 | Published online: 14 May 2013

References

  • Nissen SE , NichollsSJ, SipahiIet al. Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial. JAMA , 295(13), 1556–1565 (2006).
  • Nissen SE , TuzcuEM, BrownBGet al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. JAMA , 291, 1071–1080 (2004).
  • Nissen SE , TuzcuEM, LibbyPet al. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled study. JAMA , 292, 2217–2226 (2004).
  • Tardif JC , GregoireJ, L‘AllierPLet al. Avasimibe and progression of lesions on Ultrasound (A-PLUS) Investigators. Effects of the acyl coenzyme A: cholesterol acyltransferase inhibitor avasimibe on human atherosclerotic lesions. Circulation , 110, 3372–3377 (2004).
  • Okazaki S , YokoyamaT, MiyauchiKet al. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound ana¬lysis during half a year after coronary event: the ESTABLISH study. Circulation , 110(9), 1061–1068 (2004).
  • Nicholls SJ , BallantyneCM, BarterPJet al. Effect of two intensive statin regimens on progression of coronary disease. N. Engl. J. Med. , 365, 2078–2087 (2011).
  • Serruys PW , Garcia-GarciaHM, OnumaY. From metallic cages to transient bioresorbable scaffolds: change a paradigm of coronary revascularization in the upcoming decade? Eur. Heart J., 33(1), 16–25 (2012).
  • Glagov S , WeisenbergE, ZarinsCKet al. Compensatory enlargement of human atherosclerotic coronary arteries. N. Engl. J. Med. , 316(22), 1371–1375 (1987).
  • Douma K , MegensRT, van Zandvoort MA. Optical molecular imaging of atherosclerosis using nanoparticles: shedding new light on the darkness. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 3, 376–388 (2011).
  • Lapotko D . Therapy with gold nanoparticles and lasers: what really kills the cells? Nanomedicine, 4, 253–256 (2009).
  • Zharov VP . Photothermal imaging of nanoparticles and cells. IEEE J. Selected Topics Quant. Elect., 11, 733–751 (2005).
  • Hirsch LR . Metal NPs. Ann. Biomed. Engineer., 1(34), 15–22 (2006).
  • Khlebtsov N , AkchurinG, KhlebtsovB. Laser-induced destruction of gold NPs: new weapons in the cell-killing arsenal. SPIE, 9, 1–3 (2008).
  • Pissuwan D , ValenzuelaSM, CortieMB. Therapeutic possibilities of plasmonically heated gold nanoparticles. Trends Biotechnol., 24, 62–67 (2006).
  • Owen DR , LindsayAC, ChoudhuryRP, FayadZA. Imaging of atherosclerosis. Annu. Rev. Med., 62, 25–40 (2011).
  • Cromer Berman SM , WalczakP. Tracking stem cells using magnetic nanoparticles. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 3(4), 343–355 (2011).
  • Faulkner S , LongN. Radiopharmaceuticals for imaging and therapy. Dalton Trans., 40(23), 6067 (2011).
  • Korshunov VA , SchwartzSM, BerkC. Vascular remodeling: hemodynamic and biochemical mechanisms underlying Glagov‘s phenomenon. Arterioscler. Thromb. Vasc. Biol., 27, 1722–1728 (2007).
  • Bond MG , AdamsMR, BullockBC. Complicating factors in evaluating coronary artery atherosclerosis. Artery, 9, 21–29 (1981).
  • Weissman NJ . Vascular remodeling: do we really need yet another study? JACC, 42(5), 811–813 (2003).
  • Stack RS , CaliffRM, PhilipsIIIet al. HR Interventional cardiac catherization at Duke medical center: new interventional technology. Am. J. Cardiol., 2(F), F3–F24 (1988).
  • van der Giessen WJ , SlagenCJet al., van Beusekom HM Development of a polymer endovascular prosthesis and its implantation in porcine arteries. J. Interv. Cardiol., 5, 175–185 (1992).
  • Tietze R , RahnH, LyerSet al. Visualization of superparamagnetic nanoparticles in vascular tissue using XµCT and histology. Histochem. Cell. Biol. , 135(2), 153–158 (2011).
  • Almer G , WernigK, Saba-LepekM, Haj-YahyaSet al. Adiponectin-coated nanoparticles for enhanced imaging of atherosclerotic plaques. Int. J. Nanomed. , 6, 1279–1290 (2011).
  • Yu SS , OrtegaRA, ReaganBW, McPhersonJA, SungHJ, GiorgioTD. Emerging applications of nanotechnology for diagnosis and management of vulnerable atherosclerotic plaques. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 3, 620–646 (2011).
  • Onuma Y , MuramatsuT, KharlamovA, SerruysPW. Freeling the vessel from metallic cage: what can we achieve with bioresorbable vascular scaffolds? Cardiovasc. Interv. Ther., 27(3), 141–154 (2012).
  • Lemos PA , FarooqV, TakimuraCKet al. Emerging technologies: polymer-free phospholipid encapsulated sirolimus nanocarriers for the controlled release of drug from a stent-plus-balloon or a stand-alone balloon catheter. EuroIntervention doi:10.4244/EIJV8I0A00 (2013) (Epub ahead of print).
  • Qu M , MallidiS, MehrmohammadiMet al. Magneto-photo-acoustic imaging. Biomed. Opt. Express , 2(2), 385–395 (2011).
  • Qu M , MehrmohammadiM, EmelianovS. Detection of nanoparticle endocytosis using magneto-photoacoustic imaging. Small, 7(20), 2858–2862 (2011).
  • Wang B , EmelianovS. Thermal intravascular photoacoustic imaging. Biomed. Opt. Express, 2(11), 3072–3078 (2011).
  • Korin N , KanapathipillaiM, MatthewsBDet al. Shear-activated nanotherapeutics for drug targeting to obstructed blood vessels. Science , 337(6095), 738–742 (2012).
  • Lewis DR , KamisogluK, YorkAW, MoghePV. Polymer-based therapeutics: nanoassemblies and nanoparticles for management of atherosclerosis. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 3, 400–420 (2011).
  • Cormode DP , SkajaaTet al., van Schooneveld MM Nanocrystal role high-density lipoproteins: a multimodality contrast agent platform. Nano Lett., 8(11), 3715–3723 (2008).
  • Kharlamov A , GabinskyJ. Plasmonicnanophotothermal and stem cell therapy of atherosclerotic plaque as the novel tool for angioplasty and artery remodeling. Rejuvenation Res., 15(2), 222–230 (2012).
  • Appelman YE , KoolenJJ, PiekJJet al. Excimer laser angioplasty versus balloon angioplasty in functional and total coronary occlusions. Am. J. Cardiol. , 78, 757–762 (1996).
  • Huang X , QianW, El-SayedIHet al. The potential use of the enhanced nonlinear properties of the gold nanospheres in photothermal cancer therapy. Lasers Surg. Med. , 39, 747–753 (2007).
  • Faraday M . Experimental relations of gold (and other metals) to light. Phil. Trans. R. Soc. Lond., 147, 145–181 (1857).
  • Han W , Kohler-RedlichP, ScheuCet al. Carbon nanotubes as nanoreactors for boriding iron nanowires. Adv. Mater. , 12(18), 1356–1359 (2000).
  • van Bochove GS , PaulisLE, KramsRet al. Contrast enhancement by differently sized paramagnetic MRI contrast agents in mice with two phenotypes of atherosclerotic plaque. Contrast Media Mol. Imaging , 6(1), 35–45 (2011).
  • Chen YS , FreyW, KimSet al. Silica-coated gold nanorods as photoacoustic signal nanoamplifiers. Nano Lett. , 11(2), 348–354 (2011).
  • Choi J , KimK, KimTet al. Multimodal imaging of sustained drug release from 3-D poly(propylene fumarate) (PPF) scaffolds. J. Control. Release , 156(2), 239–245 (2011).
  • Nahrendorf M , WatermanP, ThurberGet al. Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors. Arterioscler. Thromb. Vasc. Biol. , 29, 1444–1451 (2009).
  • Day ES , ZhangL, ThompsonPAet al. Vascular-targeted photothermaltherapy of an orthotopic murine glioma model. Nanomedicine (Lond.) , 7(8), 1133–1148 (2012).
  • Ji X , ShaoR, ElliottAM, StaffordRJ, Esparza-CossEet al. Bifunctional gold nanoshells with a superparamagnetic iron oxide-silica core suitable for both MR imaging and photothermal therapy. J. Phys. Chem. C Nanomater. Interfaces , 111(17), 6245 (2007).
  • Lapotko D . Plasmonic nanoparticle-generated photothermal bubbles and their biomedical applications. Nanomedicine (Lond.), 4(7), 813–845 (2009).
  • Vader P et al. , van der Aa LJ, Storm G Polymeric carrier systems for siRNA delivery. Curr. Top. Med. Chem., 12(2), 108–119 (2012).
  • Maiocchi A , CitaddinoE, FerrarettoMet al. MRI evaluation of the antitumor activity of paramagnetic liposomes loaded with prednisolone phosphate. Eur. J. Pharm. Sci. , 45(4), 436–441 (2012).
  • Chan JM , RheeJW, DrumCLet al. In vivo prevention of arterial restenosis with paclitaxel-encapsulated targeted lipid-polymeric nanoparticles. Proc. Natl Acad. Sci. USA, 108(48), 19347–19352 (2011).
  • Al-Jamal WT , KostarelosK. Liposomes: from a clinically established drug delivery system to a nanoparticle platform for theranosticnanomedicine. Acc. Chem. Res., 44(10), 1094–1104 (2011).
  • Kunjachan S , JayapaulJ, MertensME, StormGet al. Theranostic systems and strategies for monitoring nanomedicine-mediated drug targeting. Curr. Pharm. Biotechnol. , 13(4), 609–622 (2012).
  • Kharlamov AN , TyurninaAE, VeselovaVS, NovoselovaOS, FilatovaAS, KovtunOP, ShurVY, GabinskyJL. Plasmonics for treatment of atherosclerosis: results of NANOM-FIM trial. J. Nanomed. Nanotechnol., 4, 160 (2013).
  • Nissen S , TsunodaT, TuzcuEMet al. Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes: a randomized controlled trial. JAMA , 290, 2292–2300 (2003).
  • Chang L , VillacortaL, LiRet al. Loss of perivascular adipose tissue upon PPARγ deletion in smooth muscle cells impairs intravascular thermoregulation and enhances atherosclerosis. Circulation , 126(9), 1067–1078 (2012).
  • Nam SY , RiclesLM, SuggsLJ, EmelianovSY. In vivo ultrasound and photoacoustic monitoring of mesenchymal stem cells labeled with gold nanotracers. PLoS ONE, 7(5), e37267 (2012).
  • Cai W , GaoT, HongH, SunJ. Applications of gold nanoparticles in cancer nanotechnology. Nanotech. Sci. Appl., 1, 17–32 (2008).
  • Lapotko D . Plasmonicnanobubbles as tunable cellular probes for cancer theranostics. Cancers, 3, 802–840 (2011).
  • Brugaletta S , HeoJH, Garcia-GarciaHMet al. Endothelial-dependent vasomotion in a coronary segment treated by ABSORB everolimus-eluting bioresorbable vascular scaffold system is related to plaque composition at the time of bioresorption of the polymer: indirect finding of vascular reparative therapy? Eur. Heart J. , 33(11), 1325–1333 (2012).
  • Ricles LM , NamSY, SokolovK, EmelianovSYet al. Function of mesenchymal stem cells following loading of gold nanotracers. Int. J. Nanomed. , 6, 407–416 (2011).
  • Pearce JA , CookJR, EmelianovSY. Ferrimagnetic nanoparticles enhance microwave heating for tumor hyperthermia therapy. Conf. Proc. IEEE Eng. Med. Biol. Soc., 2010, 2751–2754 (2010).
  • Homan K , ShahJ, GomezSet al. Silver nanosystems for photoacoustic imaging and image-guided therapy. J. Biomed. Opt. , 15(2), 021316 (2010).
  • Kemp SJ , ThorleyAJ, GorelikJet al. Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake. Am. J. Respir. Cell. Mol. Biol. , 39(5), 591–597 (2008).
  • Ali-Boucetta H , Al-JamalKT, MüllerKHet al. Cellular uptake and cytotoxic impact of chemically functionalized and polymer-coated carbon nanotubes. Small , 7(22), 3230–3238 (2011).
  • Almer G , Saba-LepekM, Haj-YahyaSet al. Globular domain of adiponectin: promising target molecule for detection of atherosclerotic lesions. Biologics , 5, 95–105 (2011).
  • Krams R , Yia-HerttualaS, BentzonJFet al. Stabilization of atherosclerotic plaques. Thromb. Haemost. , 106(1), 1–19 (2011).
  • Fedotenko IA , HolmeMN, TanasescuRet al. Putting the ‘p‘ into phospholipids. Chimia (Aarau) , 65(11), 859–862 (2011).
  • Winter PM , NeubauerAM, CaruthersSDet al. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. , 26, 2103–2109 (2006).
  • Klesing J , WieheA, GitterBet al. Positively charged calcium phosphate/polymer nanoparticles for photodynamic therapy. J. Mater. Sci. Mater. Med. , 21(3), 887–892 (2010).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.